Physician profile
Benjamin Shore
NPI 1902339013
$472.02
in general payments reported to CMS, 2019-2025
11 companies · $31.47 in 2025
The $31.47 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $310 · 2023: $79.60 · 2024: $50.74 · 2025: $31.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $161.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $127.99 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $122.83 | 2022 | |
| Novo Nordisk INC | $53.94 | 2023-2024 | Rybelsus, Ozempic, Wegovy |
| Braintree Laboratories, INC. | $36.51 | 2022-2023 | Sutab |
| Kci USA, INC. | $34.38 | 2022-2023 | Prevena |
| Glaxosmithkline, LLC. | $18.24 | 2022 | |
| Smith+Nephew, INC. | $18.11 | 2023 | Stravix |
| Abbvie INC. | $16.75 | 2025 | |
| Janssen Pharmaceuticals, INC | $15.48 | 2023 | Xarelto |
| Ethicon US, LLC | $14.72 | 2025 | Surgicel Nu-Knit |
| Bioventus LLC | $13.07 | 2024 | Exogen Ultrasound Bone Healing System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Shore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.